| __timestamp | Catalyst Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 84580000 |
| Thursday, January 1, 2015 | 11801342 | 86943000 |
| Friday, January 1, 2016 | 11369941 | 84493000 |
| Sunday, January 1, 2017 | 11375237 | 64988000 |
| Monday, January 1, 2018 | 19919204 | 74951000 |
| Tuesday, January 1, 2019 | 18842752 | 62331000 |
| Wednesday, January 1, 2020 | 16496715 | 28607000 |
| Friday, January 1, 2021 | 16936000 | 32228000 |
| Saturday, January 1, 2022 | 19789000 | 46600000 |
| Sunday, January 1, 2023 | 93150000 | 54886000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Catalyst Pharmaceuticals, Inc. and Dynavax Technologies Corporation have been at the forefront of this race, each investing significantly in research and development (R&D) over the past decade. From 2014 to 2023, Dynavax consistently outspent Catalyst in R&D, with an average annual investment nearly three times higher. However, 2023 marked a turning point, with Catalyst's R&D expenses surging by over 370% compared to the previous year, surpassing Dynavax for the first time. This shift highlights Catalyst's renewed commitment to innovation, potentially signaling a strategic pivot. As these companies continue to navigate the ever-evolving biotech landscape, their R&D investments will be crucial in determining their future breakthroughs and market positions.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Dynavax Technologies Corporation
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE